Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib

Subjects

Subjects :

Sorafenib
Hepatitis B virus
Oncology
medicine.medical_specialty
Hepatology
business.industry
Early disease
medicine.disease_cause
medicine.disease
Internal medicine
Potential biomarkers
Hepatocellular carcinoma
Immunology
medicine
In patient
Interleukin 17
business
medicine.drug

Details

ISSN :

01688278

Volume :

66

Database :

OpenAIRE

Journal :

Journal of Hepatology

Accession number :

edsair.doi...........5dc54c5ce3aba074e55e4c4e63e7acdd